Goldman Sachs Group Inc Gossamer Bio, Inc. Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 939,603 shares of GOSS stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
939,603
Previous 114,556
720.21%
Holding current value
$1.17 Million
Previous $103,000
902.91%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding GOSS
# of Institutions
111Shares Held
163MCall Options Held
831KPut Options Held
557K-
Octagon Capital Advisors LP New York, NY18.4MShares$22.9 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$22.6 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$12.6 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$11 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$10.1 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $117M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...